Regulatory renewal needed for UK life sciences ambitions
A new report, 'Enhancing the role of UK medicine regulation' sets out key recommendations to rebuild the UK’s world-class reputation in regulatory science, medicines’ development and licensing.
Read the full articleYou might also wanna read
The EU Parliament and the EU Council adopt a new regulation reforming the EU's foreign direct investment screening regime, introducing a common list of sensitive sectors and stricter scrutiny of investors ahead of its application from January 2028
concurrences.com·11h ago
The Japanese Government amends the Foreign Exchange and Foreign Trade Act to establish a CFIUS-style interagency committee for national security screening of foreign investment and expand review to indirect acquisitions and post-closing scrutiny
concurrences.com·14h ago
FCA reports progress on gender and disability pay gaps but ethnicity pay gap widens
incm.pub·17h agoThe EU General Court upholds a Big Tech company's gatekeeper designation for its app store and operating system under the DMA and rules its messaging-service actions inadmissible (Apple)
concurrences.com·2d ago
The UK Competition Authority publishes an updated framework document with the Department for Business and Trade setting out their governance, accountability and financial relationship
concurrences.com·2d ago
How regulation can help to unlock the potential of preventative medicines
ABPI·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.